Georg Oberhuber
About
In The Last Decade
Georg Oberhuber
150 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Surgery 2.7k
- Epidemiology 2.3k
- Gastroenterology 2.1k
- Molecular Biology 1.7k
- Cancer Research 1.4k
Countries citing papers authored by Georg Oberhuber
This map shows the geographic impact of Georg Oberhuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Oberhuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Oberhuber more than expected).
Fields of papers citing papers by Georg Oberhuber
This network shows the impact of papers produced by Georg Oberhuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Oberhuber. The network helps show where Georg Oberhuber may publish in the future.
Co-authorship network of co-authors of Georg Oberhuber
This figure shows the co-authorship network connecting the top 25 collaborators of Georg Oberhuber. A scholar is included among the top collaborators of Georg Oberhuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Oberhuber. Georg Oberhuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 26 | |
| 5 | 52 | |
| 6 | 51 | |
| 7 | 11 | |
| 8 | 120 | |
| 9 | Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. | 332 |
| 10 | 45 | |
| 11 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 159 |
| 12 | Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. | 74 |
| 13 | Empfehlungen zur Zölliakie-/Spruediagnostik Arbeitsgemeinschaft für gastroenterologische Pathologie der Deutschen Gesellschaft für Pathologie | 1 |
| 14 | 82 | |
| 15 | Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. | 40 |
| 16 | 0 | |
| 17 | 227 | |
| 18 | 11 | |
| 19 | 28 | |
| 20 | Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. | 74 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.